TRV-2026-2093Version 1 · Certified
Reason for this version
Certified into the record
Canonical text (the exact bytes fingerprinted)
TRUVACE RECORD VERSION record: TRV-2026-2093 version: 1 kind: certified reason: Certified into the record timestamp: 2026-10-21T10:42:00.630167Z status: published lens: p_space sector: health headline: Toward Explainable AI for Acute Kidney Injury Prediction in the ICU: Transparent Development, Internal Validation, and Robustness Auditing of Machine Learning Models dek: Background/Objectives: Acute kidney injury (AKI) is common in critical care, yet predictive artificial intelligence studies often differ in outcome definitions, validation, calibration, and interpretability. We developed and internally validated machine learning models for newly observed serum-creatinine-defined AKI after a fixed 24 h ICU landmark and then audited how stable the selected model was to clinically important observation and timing choices. Methods: Using MIMIC-IV v3.1, we retained one first ICU stay… gain_title: (none) problem_title: The model's outcome ascertainment depended on observation, so many eligible patients had indeterminate outcomes and calibration and threshold performance shifted under stricter observation rules. trace_subject: (none) gain_reading: (none) gain_evidence: (none) problem_reading: The model's outcome ascertainment depended on observation, so many eligible patients had indeterminate outcomes and calibration and threshold performance shifted under stricter observation rules. problem_evidence: 15,900 otherwise eligible patients had indeterminate outcomes | calibration and threshold-based performance changed under stricter observation rules quick_read: Researchers built and internally validated machine learning models to predict a new rise in serum creatinine, in line with KDIGO criteria, within 48 hours after a fixed 24-hour ICU landmark. They used one first ICU stay per adult patient from the MIMIC-IV database. Histogram gradient boosting was chosen on validation average precision and tested once on held-out patients. The work matters because AI studies for kidney injury often define outcomes, validation and calibration differently, which makes them hard to compare. Here the audit showed that results were reasonably stable across several subsets but sensitive to observation rules. The model has no external validation and no evidence of clinical benefit, so its usefulness at the bedside remains unknown. limitation: The study provides no external validation, patient-level explanation validation, or evidence of clinical benefit, and its outcome ascertainment depended on observation, leaving many patients with indeterminate outcomes. tag: Evidence-backed problem key_points: The analyzable cohort had 15,231 patients, split 60%/15%/10%/15% into training, calibration, validation and test sets. | In 2286 test patients with 664 events (29.0%), average precision was 0.523 and the Brier score was 0.179. | At a threshold fixed for at least 80% sensitivity, sensitivity was 78.5%, specificity 52.2% and positive predictive value 40.2%. | The study reports 33.9 false alerts per 100 patients at the fixed threshold. | Frozen-model sensitivity analyses gave AUROCs from 0.697 to 0.733 in most observation and measurement subsets. rundown: The cohort required adequate pre-landmark creatinine observation and excluded coded end-stage kidney disease, documented dialysis before the landmark, and AKI already observed by the landmark. Follow-up was truncated at ICU exit, hospital discharge or death. Logistic regression, random forests and histogram gradient boosting were calibrated on a separate calibration set. The selected model's AUROC was 0.0197 higher than full logistic regression (95% CI, 0.00235–0.03571), a small gain. Calibration intercept and slope were 0.023 and 1.022. A later post hoc audit reused frozen test risks without retraining. Patients with indeterminate outcomes showed substantially shorter follow-up and fewer post-landmark creatinine measurements. The authors conclude that multicenter temporal validation and prospectively defined observation rules are needed before clinical use. sources: - peer_reviewed | Information | https://doi.org/10.3390/info17101045 | 2026-10-20 prev: 0000000000000000000000000000000000000000000000000000000000000000
- sha256
- ef756d84fc1bf14858b21df77ab7ad577f9b9dcc8ef45f37c0397b0d5b2c3e2e
- previous
- 0000000000000000000000000000000000000000000000000000000000000000
Verify this record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-2093 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.
ace